
NVST Stock Forecast & Price Target
NVST Analyst Ratings
Bulls say
Envista Holdings Corp has reported a notable recovery in sales with Challenger (Value) Implant revenues returning to growth after previous declines, along with a significant increase in Premium Implant revenue both globally and within North America. The company also experienced a robust rise in sales of Wires & Brackets, evidenced by a high single-digit percentage increase year-over-year, attributed in part to strategic pricing adjustments. Additionally, Envista has raised its full-year 2025 core sales growth guidance, shifting from a range of 1-3% to 3-4% year-over-year, reflecting positive momentum in its business segments and market positioning.
Bears say
Envista Holdings Corp's financial outlook is negatively impacted by a $0.02 miss at the EBIT line despite having a top-line outperformance. Furthermore, the company's FY25 EBITDA margin guidance remains static at approximately 14%, even as core sales growth expectations have been slightly raised by 150 basis points. Additional risks include heightened competition, a potentially weakening macroeconomic environment, and challenges related to commercial execution and regulatory compliance, along with reliance on distribution partners.
This aggregate rating is based on analysts' research of Envista Holdings Corp and is not a guaranteed prediction by Public.com or investment advice.
NVST Analyst Forecast & Price Prediction
Start investing in NVST
Order type
Buy in
Order amount
Est. shares
0 shares